Researchers at UT Southwestern Medical Center have discovered how a small molecule of RNA called microRNA helps fine tune the production of a key protein involved in the early development of heart muscle.

The findings, published in journal Nature, may aid scientists in their understanding of how a progenitor cell, or stem cell, decides to become a heart cell, as well as offer researchers a way to predict how other microRNAs in the body control the production of important proteins. The discoveries could provide clues important to understanding both stem cell biology and congenital heart disease.

Scientists believe microRNAs seek out and bind to mRNA, fine tuning the amount of protein that mRNAs manufacture. In some cases, microRNAs shut down protein production altogether.

The UT Southwestern researchers discovered that a microRNA called miR-1 targets the mRNA of the gene Hand2, a key regulator of heart formation. The microRNA turns off production of the Hand2 protein at precisely the right time to allow the proper development of heart muscle.

" We think that Hand2 is necessary in the early stages of embryonic development to allow proliferation and expansion of a pool of muscle progenitor cells that can eventually develop into the heart," said Deepak Srivastava, senior author of the paper. " But at some point production of Hand2 needs to be shut off so the cells can go on to the next stage in their development and differentiate into heart muscle cells. We identified Hand2 as the target for this particular microRNA."

Srivastava said that if the microRNA is not functioning properly, heart development could be affected in many ways, including not having enough cells or having too many cells in certain locations.

" There are a variety of things that are critical to any organ's development," he said. " The Hand2 protein is a master regulator, and in its absence, you don't get any expansion of the heart ventricle at all. The finding that this microRNA controls Hand2, and probably several other proteins, is very significant."

The UT Southwestern research team is currently screening human patients with congenital heart disease for mutations in the gene miR-1 to determine what health effects such a mutation might cause. They also are studying mice and fruit flies lacking miR-1.

Srivastava said the field of microRNA studies has only recently begun to blossom. One of the key challenges is to determine which messenger RNA any given microRNA will target. Hundreds of genes are known to produce microRNA, but in vertebrates there are only three or four known targets for those hundreds.

" We are learning that microRNAs are a common mechanism through which a cell regulates itself at various stages, both during development and later in life," he said. " This is a rapid way to regulate protein levels. You can imagine a pool of messenger RNA ready to make a protein, and by virtue of a microRNA, that protein synthesis can immediately be shut off and turned back on based on a cell's environment or its needs at the time."

Source: UT Southwestern Medical Center, 2005


XagenaMedicine2005